Investors / United States / Soleus Capital
Soleus Capital
Venture capital · Greenwich, CT, United States · North America
Soleus Capital is a healthcare investment firm focused on life sciences, including biotech, medtech, diagnostics, and genomics. It invests across the healthcare lifecycle from developmental-stage companies through commercial companies.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechmedtechdiagnosticsgenomics
Your fit with Soleus Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSoleus Capital lists 4 checked portfolio companies on its own site and is named in 5 funding rounds, 1 of them as lead. Its most frequent entry is Growth, 80% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Frazier Life Sciences, Catalio Capital Management and Pivotal Life Sciences.
Counts come from funding rounds that name Soleus Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundSoleus Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 20% |
| Growth | 80% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 5 | 1 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Frazier Life Sciences | 3 |
| Catalio Capital Management | 2 |
| Pivotal Life Sciences | 2 |
| RA Capital | 2 |
| AN Venture Partners | 1 |
| ARCH Venture Partners | 1 |
| Agent Capital | 1 |
| Catalys Pacific | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Frazier Life Sciences
Compare Soleus Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Soleus Capital| Date | Company | Stage |
|---|---|---|
| 23 Oct 2026 | Series C+ | |
| 12 Aug 2026 | Series C+ Led | |
| 22 Jul 2026 | Series B | |
| 8 Jan 2026 | Series C+ |
Round details for Soleus Capital
Amounts, full round histories and every co-investor in Soleus Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops and provides organ preservation and perfusion solutions for organ transplantation. | Healthcare & Biotech | Aug 2026Series C+ | Funding round | |
| Crystalys Therapeutics develops new therapeutics to address unmet medical needs, specifically for people living with gout. | Healthcare & Biotech | Jul 2026Series B | Funding round | |
| Parabilis Medicines develops peptide therapeutics to treat serious diseases, including cancer. | Healthcare & Biotech | Jan 2026Series C+ | Funding round | |
| STAR Therapeutics discovers and develops antibody therapies for patients with serious diseases | Healthcare & Biotech | Oct 2026Series C+ | Funding round |
About this data
site last read 5 Nov 2026- Site
- soleuscapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Jan 2026
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Soleus Capital's profile as data
Pull Soleus Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/soleuscapital.com
# also
GET /v1/firms/soleuscapital.com/portfolio
GET /v1/firms/soleuscapital.com/coinvestors
GET /v1/firms/soleuscapital.com/news